FindTrial
Sign In

Effects of prorenin receptor on atherogenesis

Effects of prorenin receptor on atherogenesis - prorenin receptor and atherosclerosis

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-C000000440
Enrollment
100
Registered
2009-08-01
Start date
2006-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome, Hypertension, Hyperlipidemia, Diabetes

Interventions

inhibitor of renin-angiotensin system(RAS) carcium channel blockers

Sponsors

Keio University school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Metabolic syndrome, Hypertension, Hyperlipidemia, Diabetes

Exclusion criteria

Exclusion criteria: Cancer, prescription of RAS inhibitors, recent histry of celebrocardiovascular diseases

Design outcomes

Primary

MeasureTime frame
expression of prorenin receptor—

Countries

Japan

Contacts

Public ContactAtsuhiro Ichihara

Nephrology, endoclinology, and metabolism JG group

03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026